Influence of hyperthermic intraperitoneal chemotherapy on renal blood perfusion

Hyperthermic intraperitoneal chemotherapy (HIPEC) is accompanied with an increased risk of acute kidney injury (AKI). Whether AKI is induced by chemotoxicity or hyperthermia-related changes in renal perfusion remains controversial. The influence of HIPEC on renal perfusion has not been evaluated in...

Full description

Saved in:
Bibliographic Details
Main Authors: Liesenfeld, Lukas (Author) , Brandl, Andreas (Author)
Format: Article (Journal)
Language:English
Published: 24 May 2023
In: Langenbeck's archives of surgery
Year: 2023, Volume: 408, Issue: 1, Pages: 1-11
ISSN:1435-2451
DOI:10.1007/s00423-023-02948-8
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00423-023-02948-8
Get full text
Author Notes:Lukas F. Liesenfeld, Andreas Brandl
Description
Summary:Hyperthermic intraperitoneal chemotherapy (HIPEC) is accompanied with an increased risk of acute kidney injury (AKI). Whether AKI is induced by chemotoxicity or hyperthermia-related changes in renal perfusion remains controversial. The influence of HIPEC on renal perfusion has not been evaluated in patients yet.
Item Description:Gesehen am 05.07.2023
Physical Description:Online Resource
ISSN:1435-2451
DOI:10.1007/s00423-023-02948-8